All In Biotech

NDA 019626 · B Braun

Dextrose 70% In Plastic Container

Dextrose · Injection

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1988

Feb 2, 1988

Approved uses

1

Original approval plus efficacy supplements

Registered trials

3,797

712 Phase 3, 359 recruiting

FAERS reports

13,727

12,671 serious, 2,102 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 21, 2026.

Dextrose Injection (5% and 10%) is indicated as a source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. Dextrose Injection (5% and 10%) is indicated as a source of water and calories in adult and pediatric patients, and may also be used as a diluent for reconstitution of a powder or liquid drug product. ( 1 )

Mechanism: Dextrose provides a source of carbohydrate calories and is used to supplement nutrition by providing glucose parenterally.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Feb 2, 1988 Original approval · Type 5 - New Formulation or New Manufacturer
5 products under this application
  • DEXTROSE 70% IN PLASTIC CONTAINER · DEXTROSE 70GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 7.7% IN PLASTIC CONTAINER · DEXTROSE 7.7GM/100ML · INJECTABLE, INJECTION · Discontinued
  • DEXTROSE 2.5% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML · INJECTABLE, INJECTION · Discontinued
  • DEXTROSE 10% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Dextrose" as an intervention, any sponsor and status, largest first.

All 3,797 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • myelosuppression1,855
  • off label use1,091
  • nausea1,037
  • drug ineffective973
  • vomiting963
  • acute kidney injury807
  • pyrexia731
  • white blood cell count decreased714
  • dyspnoea683
  • sepsis588
  • abdominal pain544
  • hypotension532

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200453
200536
200649
200740
200864
200983
2010117
2011145
2012148
2013128
2014395
2015199
2016312
2017284
2018380
2019487
2020611
2021962
20221,571
20232,020
20241,949
20251,980
20261,712

Recalls

1 FDA enforcement reports for this application.

  • Apr 2, 2026 · Class II · Ongoing

    Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Shortages

FDA's drug shortage list.

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50).

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10). Available, but on 100% allocation

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10). Available, but on 100% allocation

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00). Available, but on 100% allocation

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00). Available, but on 100% allocation

  • Current · updated Nov 10, 2026

    Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20). Available, but on 100% allocation

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,414 on PubMed

Sponsor: B Braun · Also marketed as Dextrose 7.7% In Plastic Container, Dextrose 2.5% In Plastic Container, Dextrose 10% In Plastic Container, Dextrose 5% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.